1. Home
  2. TRVG vs OABI Comparison

TRVG vs OABI Comparison

Compare TRVG & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$5.27

Market Cap

375.4M

Sector

Technology

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$2.12

Market Cap

391.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVG
OABI
Founded
2005
2012
Country
Germany
United States
Employees
893
89
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
375.4M
391.4M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
TRVG
OABI
Price
$5.27
$2.12
Analyst Decision
Hold
Strong Buy
Analyst Count
6
2
Target Price
$3.95
$4.50
AVG Volume (30 Days)
120.5K
644.0K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.59
$52.42
Revenue Next Year
$8.42
$64.69
P/E Ratio
$16.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.59
$1.32
52 Week High
$5.70
$2.79

Technical Indicators

Market Signals
Indicator
TRVG
OABI
Relative Strength Index (RSI) 67.63 40.92
Support Level $2.78 $1.75
Resistance Level $5.70 $2.22
Average True Range (ATR) 0.35 0.18
MACD -0.04 -0.04
Stochastic Oscillator 64.31 9.17

Price Performance

Historical Comparison
TRVG
OABI

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: